Delivery Order SPE2DR25D3202-SPE2DR26F8E0X
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,968.36 to AmerisourceBergen Drug Corp for Xulane 150-35 micrograms per day contraceptive patches (3-pack units) on December 12, 2025, with a completion date of December 15, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,059.48 delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count) on December 11, 2025, with completion scheduled for December 12, 2025. This competitively awarded, firm fixed-price delivery order reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, serving military and veteran healthcare systems. The contract was performed at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,066.88 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack quantity) on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions through open competition and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transactional purchase under...
- The Defense Logistics Agency awarded a delivery order valued at $1,677.96 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count unit) on November 18, 2025, with completion targeted for November 19, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating open competitive procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order through its Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,524.47 to AmerisourceBergen Drug Corp for Xulane 150-35 microgram per day contraceptive patches (3-count package). This firm fixed-price, non-set-aside delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,206.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count supply) on August 21, 2025, with completion scheduled for August 22, 2025. This non-competitive delivery order was issued from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $3,793.09 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit supply) on August 27, 2025, with completion scheduled for August 28, 2025. This non-competitive delivery order was placed under firm fixed pricing terms and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,616.56 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count) on November 25, 2025, with completion expected by November 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,136.91 for Xulane 150-35 mcg/day contraceptive patches (3-count units) on July 2, 2025, with an ultimate completion date of July 3, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $11,215.32 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count) on June 18, 2025, with completion scheduled for June 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E0XDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,009.38 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack) on December 16, 2025, with completion targeted for December 17, 2025. This firm fixed-price, non-set-aside contract represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be sourced from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to compete and win awards across multiple therapeutic domains has positioned it as a critical vendor for federal medical procurement needs, with the company's contract portfolio reflecting consistent delivery of both brand-name and generic pharmaceutical products across the defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/15/25 |